menu
    • menu
    [{"orgOrder":0,"company":"Polpharma","sponsor":"Pikralida","pharmaFlowCategory":"D","therapeuticArea":"Neurology","country":"POLAND","productType":"Miscellaneous","year":"2022","type":"Partnership","leadProduct":"Marimastat","moa":"MMP","graph1":"Neurology","graph2":"Preclinical","graph3":"Polpharma","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Polpharma \/ Pikralida","highestDevelopmentStatusID":"4","companyTruncated":"Polpharma \/ Pikralida"}]

    Find Clinical Drug Pipeline Developments & Deals for Marimastat

    Menu

    Marimastat

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Polpharma

                            Poland
                            CPhI Japan
                            Attending
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual BoothEuropean CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

                            Lead Product(s) : Marimastat

                            Therapeutic Area : Neurology

                            Study Phase : Preclinical

                            Sponsor : Pikralida

                            Deal Size : Undisclosed

                            Deal Type : Partnership

                            DEALS_DEV arrow-down

                            Polpharma Partners with Pikralida Biopharmaceutical Startup

                            Details : The partnership with Marimastat aims to advance epilepsy treatment by targeting MMP.

                            Product Name : PKL-021

                            Product Type : Miscellaneous

                            Upfront Cash : Undisclosed

                            July 19, 2022

                            Lead Product(s) : Marimastat

                            Therapeutic Area : Neurology

                            Highest Development Status : Preclinical

                            Sponsor : Pikralida

                            Deal Size : Undisclosed

                            Deal Type : Partnership

                            Polpharma CB

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            • Privacy policy
                            • Terms and conditions
                            • Disclaimers
                            • LinkedIn
                            • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.